These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33312405)

  • 1. Immunophenotypic characteristics of multipotent mesenchymal stromal cells that affect the efficacy of their use in the prevention of acute graft
    Petinati N; Kapranov N; Davydova Y; Bigildeev A; Pshenichnikova O; Karpenko D; Drize N; Kuzmina L; Parovichnikova E; Savchenko V
    World J Stem Cells; 2020 Nov; 12(11):1377-1395. PubMed ID: 33312405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Cell and Cytokine Dynamics in the Blood of Patients after Hematopoietic Stem Cell Transplantation and Multipotent Mesenchymal Stromal Cell Administration.
    Petinati N; Davydova Y; Nikiforova K; Bigildeev A; Belyavsky A; Arapidi G; Drize N; Kuzmina L; Parovichnikova E; Savchenko V
    Transplant Cell Ther; 2023 Feb; 29(2):109.e1-109.e10. PubMed ID: 36372356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of bone marrow-derived mesenchymal stem cells in reduction of graft-versus-host disease by effecting CD4+CD25+ regulatory T cells in rats].
    Tian Y; Deng YB; Huang YJ; Na XD; Li Y; Ye MH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1210-4. PubMed ID: 17204196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of multipotent mesenchymal stromal cells used for acute graft-versus-host disease prophylaxis.
    Kuzmina LA; Petinati NA; Shipounova IN; Sats NV; Bigildeev AE; Zezina EA; Popova MD; Drize NJ; Parovichnikova EN; Savchenko VG
    Eur J Haematol; 2016 Apr; 96(4):425-34. PubMed ID: 26115424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Priming of Multipotent Mesenchymal Stromal Cells with Interferon γ on Their Immunomodulating Properties.
    Kapranov NM; Davydova YO; Galtseva IV; Petinati NA; Drize NI; Kuzmina LA; Parovichnikova EN; Savchenko VG
    Biochemistry (Mosc); 2017 Oct; 82(10):1158-1168. PubMed ID: 29037136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic Chondrogenic Mesenchymal Stromal Cells Alter Helper T Cell Subsets in CD4+ Memory T Cells.
    Kiernan CH; Asmawidjaja PS; Fahy N; Witte-Bouma J; Wolvius EB; Brama PAJ; Lubberts E; Farrell E
    Tissue Eng Part A; 2020 May; 26(9-10):490-502. PubMed ID: 31797740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of human bone marrow mesenchymal stem cell on allogeneic T lymphocyte phenotype in vitro].
    Ning HM; Jin JG; Hu JW; Feng K; Chen H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):43-9. PubMed ID: 15748434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model.
    Grégoire C; Ritacco C; Hannon M; Seidel L; Delens L; Belle L; Dubois S; Vériter S; Lechanteur C; Briquet A; Servais S; Ehx G; Beguin Y; Baron F
    Front Immunol; 2019; 10():619. PubMed ID: 31001253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
    Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
    Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
    J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive effects of multipotent mesenchymal stromal cells on graft-versus-host disease in rats following allogeneic bone marrow transplantation.
    Nevruz O; Avcu F; Ural AU; Pekel A; Dirican B; Safalı M; Akdağ E; Beyzadeoğlu M; Ide T; Sengül A
    Turk J Haematol; 2013 Sep; 30(3):256-62. PubMed ID: 24385804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of therapeutic role of mesenchymal stromal cells in mouse models of graft-versus-host disease using cryo-imaging.
    Wuttisarnwattana P; Eid S; Wilson DL; Cooke KR
    Sci Rep; 2023 Jan; 13(1):1698. PubMed ID: 36717650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mesenchymal stem cells for treatment of steroid-resistant chronic graft-versus-host disease].
    Zhang LS; Liu QF; Huang K; Zhang Y; Fan ZP; Huang SL
    Zhonghua Nei Ke Za Zhi; 2009 Jul; 48(7):542-6. PubMed ID: 19957792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunosuppressive effects of fetal bone marrow derived mesenchymal stem cells on in vitro proliferation of adult peripheral lymphocyte and expression of immune-related factors].
    Li F; Lyu J; Duan Y; Sun Y; Li D; Wang Y; Hu X; Xiao D
    Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):891-6. PubMed ID: 25339324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.